NCT06320600 Precision Medicine of Diabetes Program in China
| NCT ID | NCT06320600 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Xiangya Hospital of Central South University |
| Condition | Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 120,000 participants |
| Start Date | 2023-07-01 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120,000 participants in total. It began in 2023-07-01 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The prevalence of diabetes has been increasing year by year. According to the International Diabetes Federation (IDF) statistics in 2021, the global number of people with diabetes has reached 537 million. The patient population is large and heterogeneous, and precise diagnosis and treatment of diabetes patients have been a focus of attention. The objective of this study is to clarify the current status of precision classification and diagnosis of diabetes patients through retrospective and prospective cohort studies, and to establish a model for precision classification and diagnosis of diabetes, improving the accuracy of diabetes classification and diagnosis; based on big data of precision medicine for diabetes patients and follow-up cohorts, to establish precise diagnostic, therapeutic, and predictive methods for diabetes; and through multi-omics data analysis, to explore the potential pathogenesis of diabetes, explaining the heterogeneity of patients, and guiding individualized treatment for patients.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with diabetes according to WHO 1999 criteria Exclusion Criteria: * with duration more than 1 year; Diabetes has not been diagnosed by WHO standards in 1999; Absence of medical history data
Frequently Asked Questions
Who can join the NCT06320600 clinical trial?
This trial is open to participants of all sexes, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06320600 currently recruiting?
Yes, NCT06320600 is actively recruiting participants. Visit ClinicalTrials.gov or contact Second Xiangya Hospital of Central South University to inquire about joining.
Where is the NCT06320600 trial being conducted?
This trial is being conducted at Changsha, China.
Who is sponsoring the NCT06320600 clinical trial?
NCT06320600 is sponsored by Second Xiangya Hospital of Central South University. The trial plans to enroll 120,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.